Comprehensive survival analysis of stromal ILC genes in human breast cancer datasets identified a positive association with improved survival and PAPPA and TIMP2 (tissue inhibitor of metalloproteinase 2) in ILC but not IDC. This evidence concerns the gene TIMP2 and breast carcinoma.